Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT.

Hebart H, Lengerke C, Ljungman P, Paya CV, Klingebiel T, Loeffler J, Pfaffenrath S, Lewensohn-Fuchs I, Barkholt L, Tomiuk J, Meisner C, Lunenberg J, Top B, Razonable RR, Patel R, Litzow MR, Jahn G, Einsele H.

Bone Marrow Transplant. 2011 Mar;46(3):408-15. doi: 10.1038/bmt.2010.136. Epub 2010 Jun 28.

PMID:
20581879
2.

An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.

Humar A, Washburn K, Freeman R, Paya CV, Mouas H, Alecock E, Razonable RR; PV16000 Study Group.

Liver Transpl. 2007 Oct;13(10):1422-7.

3.

Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus.

Eid AJ, Brown RA, Paya CV, Razonable RR.

Transplantation. 2007 Aug 27;84(4):511-6.

PMID:
17713436
4.

Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation.

Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR.

Clin Infect Dis. 2007 May 15;44(10):1315-20. Epub 2007 Apr 11.

PMID:
17443468
5.

Effacing of the T cell compartment by cardiac transplantation in infancy.

Ogle BM, West LJ, Driscoll DJ, Strome SE, Razonable RR, Paya CV, Cascalho M, Platt JL.

J Immunol. 2006 Feb 1;176(3):1962-7.

6.

Infections and allograft rejection - intertwined complications of organ transplantation.

Razonable RR, Paya CV.

Swiss Med Wkly. 2005 Oct 1;135(39-40):571-3. No abstract available.

PMID:
16333768
7.

A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients.

Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV; PV16000 Study Group.

J Infect Dis. 2005 Oct 15;192(8):1349-54. Epub 2005 Sep 14.

PMID:
16170751
8.

Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.

Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV; PV16000 Study Group.

J Infect Dis. 2005 Oct 15;192(8):1331-9. Epub 2005 Sep 14.

PMID:
16170749
9.

A surveillance study of adenovirus infection in adult solid organ transplant recipients.

Humar A, Kumar D, Mazzulli T, Razonable RR, Moussa G, Paya CV, Covington E, Alecock E, Pescovitz MD; PV16000 Study Group.

Am J Transplant. 2005 Oct;5(10):2555-9.

10.
11.

Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta.

Trushin SA, Bren GD, Asin S, Pennington KN, Paya CV, Badley AD.

J Virol. 2005 Aug;79(15):9821-30.

12.

Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines.

Razonable RR, Henault M, Paya CV.

Toxicol Appl Pharmacol. 2006 Feb 1;210(3):181-9. Epub 2005 Jun 17.

PMID:
15964043
13.

Pharmacodynamics of oral ganciclovir and valganciclovir in solid organ transplant recipients.

Wiltshire H, Paya CV, Pescovitz MD, Humar A, Dominguez E, Washburn K, Blumberg E, Alexander B, Freeman R, Heaton N, Zuideveld KP; Valganciclovir Solid Organ Transplant Study Group.

Transplantation. 2005 Jun 15;79(11):1477-83.

PMID:
15940035
14.

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients.

Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz MD, Covington E, Alecock E; Valganciclovir Solid Organ Transplant Study Group.

Am J Transplant. 2005 May;5(5):1065-70.

15.

Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2.

Razonable RR, Henault M, Lee LN, Laethem C, Johnston PA, Watson HL, Paya CV.

Antimicrob Agents Chemother. 2005 Apr;49(4):1617-21.

16.

Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts.

Razonable RR, Paya CV.

Expert Rev Anti Infect Ther. 2004 Feb;2(1):27-41. Review.

PMID:
15482169
18.

Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4.

Vlahakis SR, Villasis-Keever A, Gomez TS, Bren GD, Paya CV.

J Infect Dis. 2003 Nov 15;188(10):1455-60. Epub 2003 Nov 18.

PMID:
14624370
19.

Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.

Dong X, Craig T, Xing N, Bachman LA, Paya CV, Weih F, McKean DJ, Kumar R, Griffin MD.

J Biol Chem. 2003 Dec 5;278(49):49378-85. Epub 2003 Sep 24.

20.

Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.

Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV.

Mol Cell Biol. 2003 Oct;23(19):7068-81.

21.

Detection of JNK and p38 activation by flow cytometry analysis.

Bou G, Villasis-Keever A, Paya CV.

Anal Biochem. 2003 Jun 15;317(2):147-55.

PMID:
12758252
22.

Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.

Razonable RR, van Cruijsen H, Brown RA, Wilson JA, Harmsen WS, Wiesner RH, Smith TF, Paya CV.

J Infect Dis. 2003 Jun 1;187(11):1801-8. Epub 2003 May 9.

PMID:
12751039
23.

Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection.

Razonable RR, Rivero A, Brown RA, Hart GD, Espy MJ, van Cruijsen H, Wilson J, Groettum C, Kremers W, Smith TF, Paya CV.

Clin Transplant. 2003 Apr;17(2):114-20.

PMID:
12709076
24.

Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients.

Feldstein AE, Razonable RR, Boyce TG, Freese DK, El-Youssef M, Perrault J, Paya CV, Ishitani MB.

Pediatr Transplant. 2003 Apr;7(2):125-9.

PMID:
12654053
25.

Prevention of fungal infection in transplantation.

Paya CV.

Transpl Infect Dis. 2002;4 Suppl 3:46-51. Review.

PMID:
12486792
26.

G protein-coupled chemokine receptors induce both survival and apoptotic signaling pathways.

Vlahakis SR, Villasis-Keever A, Gomez T, Vanegas M, Vlahakis N, Paya CV.

J Immunol. 2002 Nov 15;169(10):5546-54.

27.

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.

Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, Wiesner R, Paya CV.

Clin Infect Dis. 2002 Oct 15;35(8):974-81. Epub 2002 Sep 26.

PMID:
12355385
28.

Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope.

Omiya R, Buteau C, Kobayashi H, Paya CV, Celis E.

J Immunol. 2002 Aug 15;169(4):2172-9.

29.

The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation.

Razonable RR, Paya CV.

Liver Transpl. 2002 Aug;8(8):651-8. Review.

30.

A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation.

Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O'Brien PC, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL.

Transplantation. 2002 Jun 27;73(12):1904-9.

PMID:
12131685
31.

CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells.

Algeciras-Schimnich A, Vlahakis SR, Villasis-Keever A, Gomez T, Heppelmann CJ, Bou G, Paya CV.

AIDS. 2002 Jul 26;16(11):1467-78.

PMID:
12131184
32.

Cytomegalovirus (CMV) resistance to antivirals.

Drew WL, Paya CV, Emery V.

Am J Transplant. 2001 Nov;1(4):307-12. Review.

33.

Cryptosporidiosis.

Chen XM, Keithly JS, Paya CV, LaRusso NF.

N Engl J Med. 2002 May 30;346(22):1723-31. Review. No abstract available.

PMID:
12037153
34.

Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.

Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.

Liver Transpl. 2002 Apr;8(4):362-9.

35.

Economic impact of cytomegalovirus in solid organ transplantation.

Paya CV.

Transpl Infect Dis. 2001;3 Suppl 2:14-9.

PMID:
11926744
36.

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease.

Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV.

Transplantation. 2002 Mar 27;73(6):968-73.

PMID:
11923702
37.

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

Paya CV, Wilson JA, Espy MJ, Sia IG, DeBernardi MJ, Smith TF, Patel R, Jenkins G, Harmsen WS, Vanness DJ, Wiesner RH.

J Infect Dis. 2002 Apr 1;185(7):854-60. Epub 2002 Mar 19.

PMID:
11920308
38.
39.

Kaposi's Sarcoma and Transplantation.

Mendez JC, Paya CV.

Herpes. 2000 Feb;7(1):18-23.

PMID:
11866996
40.

Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts.

Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV.

J Infect Dis. 2002 Jan 1;185(1):110-3. Epub 2001 Dec 14.

PMID:
11756989
41.

Transcription of the RelB gene is regulated by NF-kappaB.

Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya CV.

Oncogene. 2001 Nov 22;20(53):7722-33.

42.

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.

Razonable RR, Rivero A, Rodriguez A, Wilson J, Daniels J, Jenkins G, Larson T, Hellinger WC, Spivey JR, Paya CV.

J Infect Dis. 2001 Dec 1;184(11):1461-4. Epub 2001 Oct 23.

PMID:
11709790
43.

Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.

Razonable RR, Brown RA, Espy MJ, Rivero A, Kremers W, Wilson J, Groettum C, Smith TF, Paya CV.

J Clin Microbiol. 2001 Dec;39(12):4472-6.

44.
45.

RelB cellular regulation and transcriptional activity are regulated by p100.

Solan NJ, Miyoshi H, Carmona EM, Bren GD, Paya CV.

J Biol Chem. 2002 Jan 11;277(2):1405-18. Epub 2001 Oct 30.

46.

Indirect effects of CMV in the solid organ transplant patient.

Paya CV.

Transpl Infect Dis. 1999;1 Suppl 1:8-12. Review.

PMID:
11565588
47.

Prevention of infections in solid organ transplant recipients.

Villacian JS, Paya CV.

Transpl Infect Dis. 1999 Mar;1(1):50-64. Review.

PMID:
11428971
48.

Prevention of fungal and hepatitis virus infections in liver transplantation.

Paya CV.

Clin Infect Dis. 2001 Jul 1;33 Suppl 1:S47-52. Review.

PMID:
11389522
49.

Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis.

Chen XM, Levine SA, Splinter PL, Tietz PS, Ganong AL, Jobin C, Gores GJ, Paya CV, LaRusso NF.

Gastroenterology. 2001 Jun;120(7):1774-83.

PMID:
11375958
50.

Fusarium infection after solid-organ transplantation.

Sampathkumar P, Paya CV.

Clin Infect Dis. 2001 Apr 15;32(8):1237-40. Epub 2001 Mar 27. Review.

PMID:
11283817

Supplemental Content

Support Center